Forty Oxycodone for a Fifteen-Year-Old
A 15-year-old boy has three third molars removed on a Friday afternoon by Dr. Patel in Raleigh. The surgery is uncomplicated. The mother says her son 'can't take ibuprofen because it upsets his stomach' and asks for 'something strong.' Dr. Patel writes a paper prescription for oxycodone 5 mg, 40 tablets, one every 4 to 6 hours as needed, no refills, because his e-prescribing software is down. He does not query the CSRS, although he is registered. The chart's medication list includes alprazolam 0.5 mg twice daily prescribed by a psychiatrist, but Dr. Patel did not review it before prescribing. The next morning the mother calls saying the boy is sleepy and nauseated; the father mentions the alprazolam. The practice has no written opioid policy and no one has explained naloxone to the family.
1. Identify the prescribing, CSRS, and documentation failures in this encounter.
Read the worked answer
Several failures compound one another. First, North Carolina requires a prescriber to check the CSRS before prescribing a Schedule II opioid; Dr. Patel did not, so he missed both the alprazolam and any other controlled-substance history. Second, the combination of an opioid with a benzodiazepine in a 15-year-old is a recognized high-risk combination for respiratory depression and should have triggered a reconsideration of the opioid altogether. Third, the quantity exceeds North Carolina's limits for an initial opioid prescription for acute pain; post-surgical dental pain generally allows at most a 7-day supply, and 40 tablets at the written directions can exceed that. Fourth, the paper-prescription exception for e-prescribing failure must be documented and retained, not merely asserted. Finally, the record lacks a review of the medication list, a rationale for choosing an opioid over non-opioid alternatives, and any naloxone education.
2. What should Dr. Patel do immediately for this patient?
Read the worked answer
He should treat the call as a possible adverse drug event, not a nuisance call. He should ask about level of consciousness, respiratory rate, snoring, color, and whether the boy can be aroused; if there is excessive sedation or breathing difficulty, the family should call 911 or go to the emergency department. If the boy is stable, Dr. Patel should advise stopping the oxycodone, use acetaminophen and a non-opioid alternative that the stomach can tolerate, and notify the prescribing psychiatrist about the overlapping prescriptions. He should prescribe or arrange naloxone and teach the family how to use it, document the conversation, and schedule a follow-up call. The opioid should not simply be continued at a lower dose without reassessing the benzodiazepine interaction and the patient's airwav risk.
3. What sanctions or corrective actions are likely if the Board and DEA review this prescribing?
Read the worked answer
The Board can pursue discipline for unprofessional conduct, failure to meet the standard of care, and failure to comply with the CSRS check requirement. The DEA may separately examine whether the prescription was issued for a legitimate medical purpose and within the prescriber's authority. Likely corrective actions include a consent order, a civil penalty, continuing education in opioid prescribing and pain management, a chart audit or practice monitor, and a written office opioid policy. The absence of documentation is aggravating because it prevents the dentist from showing what was considered. Early remediation, including naloxone education and a change in prescribing practice, may mitigate the sanction but does not erase the CSRS violation.